Federal Reserve Grinch Tries to Steal Christmas from Stock Market
The S&P 500 (Index: SPX) had a rough week just ahead of the Christmas and New Years holidays.
The rough going was courtesy of the grinches at the Federal Reserve, who did their best to steal Christmas from investors by putting the kibosh on the prospects for more than two interest rate cuts in 2025. Since we covered the immediate aftermath of their Scrooge-like pronouncements, all that’s left to cover is what happened after that.
What happened after the Fed’s final announcement of 2024 is the S&P 500 managed to recover one of the three percent it lost on Wednesday, 18 December 2024. The index closed at 5,930.87, down two percent from where it ended the preceding week.
After the Fed reduced the Federal Funds Rate by a quarter point to a target range of 4.25-4.50% and signaled they weren’t planning more than two rate cuts in 2025, the CME Group’s FedWatch Tool dropped all but one rate cut from its forecast for all of 2025. The remaining projected rate cut is a 0.25% reduction in the Federal Funds Rate on 7 May (2025-Q2).
Not uncoincidentally, that’s the future quarter upon which investors are focusing their attention. The latest update shows the late week rebound in stock prices that falls within the range associated with 2025-Q2 that the dividend futures-based model has been projecting for the index.
Here is the full trading week’s worth of market moving headlines:
- Monday, 16 December 2024
-
- Signs and portents for the U.S. economy:
- Oil prices drop on soft Chinese spending data
- US factory activity slumps further in December as tariffs loom
- Fed minions get some better economic data:
- Mixed economic signs developing in China:
- China November industrial output rises 5.4%, above expectations
- China sees slowest home price decline in 17 months amid signs of stabilisation
- China’s property investment falls 10.4% y/y in Jan-Nov
- Bigger trouble developing in Japan, some hope on horizon:
- Japan’s factory activity softens for 6th straight month, PMI shows
- Japan October machinery orders rise on strong manufacturing sector
- Bigger trouble developing in Eurozone less bad, Germany is worse:
- ECB minions thinking they should probably keep cutting Eurozone interest rates:
- ECB should keep cutting rates in small steps, Kazimir says
- ECB expects more rate cuts as inflation fears abate
- Nasdaq logs record close, S&P up as Wall Street looks for final 2024 rate cut; Dow down
- US bond investors brace for ‘hawkish cut,’ spurn long-term bonds
- Tuesday, 17 December 2024
-
- Signs and portents for the U.S. economy:
- Oil prices in holding pattern ahead of Federal Reserve decision
- Half US at high risk of power shortfall in next decade, regulator says
- US manufacturing output rebounds less than expected in November
- Fed caution, inflation risks propel US Treasury yield forecasts higher again
- Bigger trouble, stimulus developing in China:
- China capital markets witness record outflows in Nov, official data shows
- Exclusive: China plans record budget deficit of 4% of GDP in 2025, say sources
- BOJ minions expected to boldly do nothing with Japan’s interest rates:
- ECB minion say they’ll make Eurozone monetary policy up as they go:
- S&P, Nasdaq fall, Dow marks longest losing run since 1978 before Fed’s last 2024 meeting
- Wednesday, 18 December 2024
-
- Signs and portents for the U.S. economy:
- US single-family housing starts rebound; tariffs an obstacle
- US current account deficit hits record high in the third quarter
- Oil settles up after US crude stocks fall, Fed’s 2025 outlook curbs gains
- Fed minions cut rates, dial back plans for more rate cuts because of persistent Bidenflation:
- Fed lowers rates but projects slower pace of further cuts, firmer inflation
- Fed cuts reverse repo rate by wider margin than funds rate target
- Fed policymakers project two quarter-point rate cuts next year
- US rate futures price in Fed on hold in January, less than two cuts in 2025
- VIEW Fed cuts rates 25 bp, scales back 2025 easing projections
- BOJ minions seek answers to philosophical questions:
- Nasdaq slides more than 2%, yields jump as Fed sees fewer rate cuts, stresses caution
- Thursday, 19 December 2024
-
- Signs and portents for the U.S. economy:
- Oil drops as dour economic outlook adds to oversupply concerns
- Philly Fed’s manufacturing gauge slumps to 20-month low
- US existing home sales jump to eight-month high in November
- US mortgage rates rise after three straight weekly declines
- Seeing low-income consumers squeezed, retailers target $10 and under gifts
- Fed minions causing problems elsewhere in the world:
- Fed’s hawkish tilt has emerging markets scurrying to save currencies
- More hawkish Fed policy committee may increase dissent in 2025
- Central banks taking other actions, or not, with their interest rates:
- Bank of England keeps rates steady, policy split widens
- BOJ keeps ultra-low rates, gives few clues on when it might hike
- BOJ Governor Ueda’s comments at news conference
- BOJ keeps rates steady by 8-1 vote, board member Tamura dissents
- New Zealand sinks into recession, more rate cuts coming
- ECB minions claim they don’t need to stimulate Eurozone economy:
- Wall Street rebound fizzles out, but Dow snaps longest losing streak since 1974
- Friday, 20 December 2024
-
- Signs and portents for the U.S. economy:
- Fed’s Favored Inflation Gauge Brings Some Good News
- Bird flu drives US egg prices to all-time highs before Christmas
- Oil falls 1% on demand growth concerns, robust dollar
- Fed minions try to explain why they’ve gone cold toward rate cuts in 2025:
- Fed’s Williams says Fed remains on track for cuts, amid uncertain outlook
- Fed’s Goolsbee says policy uncertainty led to his shift on rate-cut path
- Fed’s Hammack says economic strength argued against rate cut
- BOJ minions sad they can’t keep never-ending stimulus alive:
- Bank of Japan bids final farewell to Kuroda’s radical policy experiment
- Japan’s core inflation accelerates, keeps BOJ rate-hike chance alive
- Stocks rally after inflation data but close lower for the week
The Atlanta Fed’s GDPNow tool‘s projection of the real GDP growth rate for the current quarter of 2024-Q3 declined to +3.1% from the previous week’s +3.3% annualized growth estimate.
Looking ahead, the next weeks should be relatively quiet in terms of market moving news for the markets, which will hopefully provide the conditions needed to deliver a traditional Santa Claus rally. We’ll pick up the plot in the new year with the first 2025 edition of the S&P 500 chaos series on Monday, 6 January 2025.
Image credit: Microsoft Copilot Designer. Prompt: “An editorial cartoon of a Federal Reserve official dressed as the Grinch who is trying to steal Christmas”
Source: https://politicalcalculations.blogspot.com/2024/12/federal-reserve-grinch-tries-to-steal.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.